Skip to content

Decoding the Genetic Landscape of Congenital Congenital Anomalies of the Kidney and Urinary tract: A Prospective Multicenter Cohort Study

Decoding the Genetic Landscape of Congenital Congenital Anomalies of the Kidney and Urinary tract: A Prospective Multicenter Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105863
Enrollment
Unknown
Registered
2025-07-14
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Anomalies of the Kidney and Urinary tract

Interventions

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 0 years <= age <= 90 years, regardless of gender. 2. Radiological Diagnosis of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT): Including: Renal Dysplasia (Aplasia, hypoplasia, dysplasia, and ectopic kidneys), Obstructive Uropathies (Ureteropelvic junction obstruction (UPJO), vesicoureteral reflux (VUR), posterior urethral valves (PUV), etc), Collecting System Anomalies (Duplicated renal pelvis and ureter, megaureter, ureterocele, etc.). 3. Informed Consent: The patient or their legal guardian has signed a written informed consent form, agreeing to participate in clinical follow-up and biosample collection. 4. Availability of Data and Follow-Up: The patient must be able to provide a complete clinical history, demographic information, radiological data, and be available for regular follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Non-Congenital Malformations: Acquired kidney or urinary tract diseases (such as stones, tumors, post-traumatic deformities) or urinary tract abnormalities secondary to infections, medications, or metabolic disorders. 2. Presence of Malignant or Benign Tumors: Any known neoplastic conditions. 3. Known chromosomal anomalies (e.g., 17q12 deletion syndrome, 22q11.2 microdeletion) or multisystem syndromes (e.g., Branchio-Oto-Renal syndrome). 4. Inability or Refusal to Cooperate with Follow-Up: Patients who are unable or unwilling to participate in follow-up visits or refuse to provide necessary clinical information.

Design outcomes

Primary

MeasureTime frame
Gene sequence;Subtype classification;Radiological parameters;

Secondary

MeasureTime frame
Renal function;Complications;

Countries

China

Contacts

Public ContactXuesong Li

Peking University First Hospital

pineneedle@sina.com+86 183 5652 9939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026